Method for the preparation of in vitro-derived human neutrophil precursor cells
Patent Number: 5700691
Date of First Priority Issue: Monday March 23rd, 1992
Date Issued: Tuesday December 23rd, 1997
Assignee: Baxter Healthcare Inc. (Irvine, CA)
Inventors: Bender, James G. (Lindenhurst, IL); Maples, Phillip B. (Waukegan, IL); Smith, Stephen (Arlington Heights, IL); Unverzagt, Kristen L. (Palatine, IL); Van Epps, Dennis E. (Cary, IL)
This patent teaches how to differentiate hematopoietic stem cells into a type of stem cell that is committed to the neutrophil lineage. These "committed" stem cells may be administered into a neutropenic patient until endogenous neutrophils rebound.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking: